FDA Lead Scientist Discusses 22nd Century’s SPECTRUM® Research Cigarettes in Public Webcast

World News: . []

22nd Century Group Inc NYSE American XXII a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco announced today that on October 11 2018 Dr Lynn Hull Lead Pharmacologist a t the U...

More news and information about 22nd Century Group, Inc.

Published By:

Business Wire: 15:20 GMT Friday 12th October 2018

Published: .

Search for other references to "lead" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us